Nektar Therapeutics (NKTR) Tops Q3 EPS by 1c

November 9, 2012 4:11 PM

Nektar Therapeutics (NASDAQ: NKTR) reported Q3 EPS of ($0.38), $0.01 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found